B Menezes,
E Khera, M Calopiz, MD Smith, ML Ganno… - The AAPS journal, 2022 - Springer
The development of new antibody–drug conjugates (ADCs) has led to the approval of 7
ADCs by the FDA in 4 years. Given the impact of intratumoral distribution on efficacy of these …